Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudius Mueller

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Proteomics. Clinical Applications|August 6, 2014
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cellsLorenzo Colarossi, Lorenzo Memeo, Cristina Colarossi, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2012
Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal studyMatthew Zabel, Matthew Schrag, Claudius Mueller, et al.
Virology|September 28, 2014
Inhibition of host extracellular signal-regulated kinase (ERK) activation decreases new world alphavirus multiplication in infected cellsKelsey Voss, Moushimi Amaya, Claudius Mueller, et al.
Biotechniques|September 6, 2012
Improved data normalization methods for reverse phase protein microarray analysis of complex biological samplesAntonella Chiechi, Claudius Mueller, Kevin M Boehm, et al.
Cureus|March 29, 2021
Proteomic Analysis of Cardioembolic and Large Artery Atherosclerotic Clots Using Reverse Phase Protein Array Technology Reveals Key Cellular Interactions Within Clot MicroenvironmentsMehdi Abbasi, Sean Fitzgerald, Jennifer Ayers-Ringler, et al.
Scientific Reports|November 24, 2019
A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistanceJustin B Davis, Sreshta S Krishna, Ryan Abi Jomaa, et al.
Pathogens and Disease|February 4, 2014
Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseasesMoushimi Amaya, Alan Baer, Kelsey Voss, et al.
Alzheimer Disease and Associated Disorders|June 27, 2008
Longitudinal metabolic and cognitive changes in mild cognitive impairment patientsBrenda L Bartnik Olson, Barbara A Holshouser, William Britt, et al.
Cancer Research|December 19, 2013
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlationsClaudius Mueller, Ana C deCarvalho, Tom Mikkelsen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 20, 2019
Unlocking bone for proteomic analysis and FISHClaudius Mueller, Marco Gambarotti, Stefania Benini, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Proteomics. Clinical Applications|August 6, 2014
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cellsLorenzo Colarossi, Lorenzo Memeo, Cristina Colarossi, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2012
Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal studyMatthew Zabel, Matthew Schrag, Claudius Mueller, et al.
Virology|September 28, 2014
Inhibition of host extracellular signal-regulated kinase (ERK) activation decreases new world alphavirus multiplication in infected cellsKelsey Voss, Moushimi Amaya, Claudius Mueller, et al.
Biotechniques|September 6, 2012
Improved data normalization methods for reverse phase protein microarray analysis of complex biological samplesAntonella Chiechi, Claudius Mueller, Kevin M Boehm, et al.
Cureus|March 29, 2021
Proteomic Analysis of Cardioembolic and Large Artery Atherosclerotic Clots Using Reverse Phase Protein Array Technology Reveals Key Cellular Interactions Within Clot MicroenvironmentsMehdi Abbasi, Sean Fitzgerald, Jennifer Ayers-Ringler, et al.
Scientific Reports|November 24, 2019
A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistanceJustin B Davis, Sreshta S Krishna, Ryan Abi Jomaa, et al.
Pathogens and Disease|February 4, 2014
Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseasesMoushimi Amaya, Alan Baer, Kelsey Voss, et al.
Alzheimer Disease and Associated Disorders|June 27, 2008
Longitudinal metabolic and cognitive changes in mild cognitive impairment patientsBrenda L Bartnik Olson, Barbara A Holshouser, William Britt, et al.
Cancer Research|December 19, 2013
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlationsClaudius Mueller, Ana C deCarvalho, Tom Mikkelsen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 20, 2019
Unlocking bone for proteomic analysis and FISHClaudius Mueller, Marco Gambarotti, Stefania Benini, et al.
Pageof 6